# Optimization of Biotinylation Protocol for Studies of Red Blood Cell Survival and Function After Transfusion

> **NCT06788080** · EARLY_PHASE1 · COMPLETED · sponsor: **Vitalant Research Institute** · enrollment: 12 (actual)

## Conditions studied

- Measuring Red Blood Cell Survival After Transfusion

## Interventions

- **DRUG:** BioRBC

## Key facts

- **NCT ID:** NCT06788080
- **Lead sponsor:** Vitalant Research Institute
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-07
- **Primary completion:** 2024-11-04
- **Final completion:** 2024-11-04
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2025-01-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06788080

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06788080, "Optimization of Biotinylation Protocol for Studies of Red Blood Cell Survival and Function After Transfusion". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06788080. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*